FDA Inspection 1293934 — Zhejiang Dayang Biotech Group Co. Ltd.
The FDA completed an inspection of Zhejiang Dayang Biotech Group Co. Ltd. on Nov 20, 2025 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 20, 2025
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)